Holen Sie sich die Stockscreener-App
8.10
1.58%
-0.13
Handel nachbörslich:
8.31
0.21
+2.59%
Schlusskurs vom Vortag:
$8.23
Offen:
$8.21
24-Stunden-Volumen:
557.50K
Relative Volume:
0.59
Marktkapitalisierung:
$418.32M
Einnahmen:
$742.90M
Nettoeinkommen (Verlust:
$52.60M
KGV:
9.7649
EPS:
0.8295
Netto-Cashflow:
$156.80M
1W Leistung:
+0.62%
1M Leistung:
-2.29%
6M Leistung:
-11.38%
1J Leistung:
+79.20%
1-Tages-Spanne:
$8.09
$8.3209
1-Wochen-Bereich:
$8.065
$8.54
52-Wochen-Spanne:
$4.02
$14.06
Emergent Biosolutions Inc Stock (EBS) Company Profile
Firmenname
Emergent Biosolutions Inc
Sektor
Telefon
240-631-3200
Adresse
300 PROFESSIONAL DR, GAITHERSBURG, MD
Compare EBS vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EBS
Emergent Biosolutions Inc
|
8.10 | 425.03M | 742.90M | 52.60M | 156.80M | 0.8295 |
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
118.26 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.92 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.82 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
559.65 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-08-22 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-03-07 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-11-20 | Fortgesetzt | JP Morgan | Underweight |
| 2023-08-29 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-04-10 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-03-17 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-11-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-04-29 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-01-20 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2021-11-08 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2021-05-05 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Eingeleitet | The Benchmark Company | Buy |
| 2021-02-24 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2021-02-19 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2021-01-08 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-09-14 | Fortgesetzt | JP Morgan | Neutral |
| 2020-07-31 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-09-04 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2018-11-02 | Hochstufung | Goldman | Neutral → Buy |
| 2018-08-03 | Bestätigt | Chardan Capital Markets | Buy |
| 2018-06-13 | Eingeleitet | Argus | Buy |
| 2018-04-25 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2018-01-16 | Bestätigt | Chardan Capital Markets | Buy |
| 2016-06-28 | Bestätigt | Singular Research | Buy |
| 2016-04-15 | Eingeleitet | Chardan Capital Markets | Buy |
| 2016-03-28 | Eingeleitet | Singular Research | Buy |
| 2016-02-19 | Eingeleitet | Wells Fargo | Outperform |
| 2014-05-15 | Eingeleitet | Summer Street Research | Buy |
| 2011-05-31 | Bestätigt | WBB Securities | Strong Buy |
| 2011-01-10 | Bestätigt | Wedbush | Outperform |
| 2010-11-05 | Bestätigt | Wedbush | Outperform |
| 2010-08-18 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2010-08-06 | Bestätigt | Caris & Company | Buy |
Alle ansehen
Emergent Biosolutions Inc Aktie (EBS) Neueste Nachrichten
Emergent BioSolutions Inc. (EBS) Stock Price, News, Quote & History - Yahoo! Finance Canada
EBS PE Ratio & Valuation, Is EBS Overvalued - Intellectia AI
Emergent BioSolutions Inc. (EBS) stock price, news, quote and history - Yahoo Finance UK
Emergent BioSolutions Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Insider Sell: Paul Williams Sells 4,000 Shares of Emergent BioSo - GuruFocus
Emergent BioSolutions (NYSE: EBS) SVP sells 4,000 shares - stocktitan.net
Emergent Biosolutions directs 2026 Cycle A donations to public health and scientific outreach - Traders Union
Emergent BioSolutions Participates in Upcoming International Preparedness Conferences - bitget.com
Emergent joins 4 health security events from London to Kuala Lumpur - stocktitan.net
[144] Emergent BioSolutions Inc. SEC Filing - stocktitan.net
Chart Watch: Is Emergent BioSolutions Inc stock forming a triangle patternEarnings Performance Report & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Emergent BioSolutions (EBS) price target decreased by 11.11% to 12.24 - MSN
Risks Report: Is Emergent BioSolutions Inc stock showing strong momentumShort Setup & Weekly Sector Rotation Insights - baoquankhu1.vn
Emergent BioSolutions Inc. (EBS) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union
Vanguard disaggregates holdings; reports zero Emergent BioSolutions stake (NYSE: EBS) - Stock Titan
Decliners Report: Can Emergent BioSolutions Inc grow without external fundingQuarterly Profit Report & Accurate Intraday Trading Signals - baoquankhu1.vn
H.C. Wainwright reiterates Emergent BioSolutions stock rating on contract wins - Investing.com Australia
H.C. Wainwright reiterates Emergent BioSolutions stock rating on contract wins By Investing.com - Investing.com South Africa
Emergent BioSolutions secures $60.6M in smallpox contracts By Investing.com - Investing.com Australia
Emergent BioSolutions secures $60M contracts - MSN
Emergent Biosolutions stock rises on $54M government contract By Investing.com - Investing.com Canada
How The Reset Price Target Is Shaping The Emergent BioSolutions (EBS) Investment Story - finance.yahoo.com
Emergent Biosolutions stock rises on $54M government contract - Investing.com
Emergent BioSolutions (EBS) Secures $54M Smallpox Preparedness C - GuruFocus
Emergent BioSolutions Gets $54 Million Contract Award for Smallpox Preparedness - marketscreener.com
Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical Countermeasures - Bitget
Emergent BioSolutions secures $60.6M in smallpox contracts - Investing.com
Q&A: Emergent BioSolutions Lands $60M+ in Smallpox Preparedness Deals — What’s the Impact? - citybiz
Emergent Biosolutions wins fresh U.S. government agreement and boosts international orders - Traders Union
Emergent Biosolutions introduces new NARCAN Nasal Spray carrying cases to support overdose response - Traders Union
Emergent BioSolutions authorizes $50 million stock repurchase program - MSN
Smart Money: Can Emergent BioSolutions Inc stock outperform in a bear marketTake Profit & Daily Chart Pattern Signals - baoquankhu1.vn
Emergent BioSolutions (NYSE: EBS) details 2026 votes on board, pay and stock plan - Stock Titan
Emergent BioSolutions signs contract modification award for CNJ-016 - MSN
U.S. Smallpox Treatment Market: See Incredible Growth - openPR.com
Mpox Is on the Rise in the U.S. 3 Vaccine Stocks Worth a Second Look. - Barron's
Emergent BioSolutions outlines $720M–$760M 2026 revenue target as transformation plan advances - MSN
EBS Stock Price, Quote & Chart | EMERGENT BIOSOLUTIONS INC (NYSE:EBS) - ChartMill
How The Investment Narrative For Emergent BioSolutions (EBS) Is Shifting After The $12 Target Reset - Yahoo Finance
BioThrax (Emergent BioSolutions) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F - Yahoo Finance
H.C. Wainwright cuts Emergent BioSolutions stock price target on revenue miss - Investing.com Nigeria
Finanzdaten der Emergent Biosolutions Inc-Aktie (EBS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.35%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):